- Home
- ADCT vs PVBC Comparison
ADCT vs PVBC Comparison
Compare ADCT & PVBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADCT
- PVBC
- Stock Information
- Founded
- ADCT 2011
- PVBC 1913
- Country
- ADCT Switzerland
- PVBC United States
- Employees
- ADCT N/A
- PVBC N/A
- Industry
- ADCT Biotechnology: Pharmaceutical Preparations
- PVBC Major Banks
- Sector
- ADCT Health Care
- PVBC Finance
- Exchange
- ADCT Nasdaq
- PVBC Nasdaq
- Market Cap
- ADCT 241.0M
- PVBC 202.6M
- IPO Year
- ADCT 2020
- PVBC 2015
- Fundamental
- Price
- ADCT $2.78
- PVBC $11.84
- Analyst Decision
- ADCT Strong Buy
- PVBC Hold
- Analyst Count
- ADCT 6
- PVBC 1
- Target Price
- ADCT $7.80
- PVBC $12.50
- AVG Volume (30 Days)
- ADCT 937.9K
- PVBC 308.9K
- Earning Date
- ADCT 08-05-2025
- PVBC 07-28-2025
- Dividend Yield
- ADCT N/A
- PVBC N/A
- EPS Growth
- ADCT N/A
- PVBC N/A
- EPS
- ADCT N/A
- PVBC 0.26
- Revenue
- ADCT $75,817,000.00
- PVBC $50,244,000.00
- Revenue This Year
- ADCT $10.65
- PVBC $9.73
- Revenue Next Year
- ADCT $15.05
- PVBC $4.87
- P/E Ratio
- ADCT N/A
- PVBC $45.29
- Revenue Growth
- ADCT 10.49
- PVBC N/A
- 52 Week Low
- ADCT $1.05
- PVBC $9.48
- 52 Week High
- ADCT $4.13
- PVBC $12.96
- Technical
- Relative Strength Index (RSI)
- ADCT 47.62
- PVBC 64.66
- Support Level
- ADCT $3.21
- PVBC $11.66
- Resistance Level
- ADCT $3.97
- PVBC $11.91
- Average True Range (ATR)
- ADCT 0.38
- PVBC 0.18
- MACD
- ADCT -0.12
- PVBC 0.02
- Stochastic Oscillator
- ADCT 3.43
- PVBC 70.11
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).
About PVBC Provident Bancorp Inc. (MD)
Provident Bancorp Inc provides a range of banking products and services to small and medium-sized commercial customers. It attracts deposits from the general public and uses those funds to originate loans, commercial real estate, construction and land, and commercial business loans, and to invest in securities. The company lending activities include providing commercial real estate loans, multi-family residential real estate loans, commercial business loans, construction and land development loans, one-to four-family residential loans, home equity loans & lines of credit, and consumer loans.